Search Results21-25 of  25

  • 2 / 2
  • Ioka Tatsuya ID: 9000325834534

    Articles in CiNii:1

    • Pharmacokinetic study of adjuvant gemcitabine therapy for biliary tract cancer following major hepatectomy (KHBO1101) (2015)
  • Ioka Tatsuya ID: 9000326656677

    )Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan (2015 from CiNii)

    Articles in CiNii:1

    • Development of plasma biomarker for early stage pancreatic cancer and risk factors of pancreatic malignancy (2015)
  • Ioka Tatsuya ID: 9000399009419

    Articles in CiNii:1

    • Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics (2017)
  • Ioka Tatsuya ID: 9000403150556

    Department of Cancer Survey and Gastrointestinal Oncology, Osaka International Cancer Institute, Japan (2020 from CiNii)

    Articles in CiNii:1

    • Phase I/II Study: Experience with the Late Onset of Acute Pancreatitis after the Start of Chemotherapy with Gemcitabine Plus nab-Paclitaxel for Metastatic Pancreatic Cancer (2020)
  • Tatsuya Ioka ID: 9000403961150

    Articles in CiNii:1

    • TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial) (2019)
  • 2 / 2
Page Top